Stock-Based Compensation

$1.43B

Quarterly · Period ending: Jun 30, 2026 · USD

Latest reported$1.43Bperiod endingJun 30, 2026

MNPR Quarterly Stock-Based Comp ($0.00 → $1.43B)

Quarterly stock-based compensation

High-resolution chart · PNG

MNPR stock-based compensation history

Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Monopar Therapeutics Inc Stock-Based Compensation — Quarterly (USD)
Period ending	Stock-Based Compensation (USD)
Jun 30, 2026	1,428,451,000
Mar 31, 2026	1,692,980
Dec 31, 2025	1,104,104
Sep 30, 2025	1,099,210
Jun 30, 2025	1,279,546
Mar 31, 2025	1,355,017
Dec 31, 2024	278,612
Sep 30, 2024	199,122
Jun 30, 2024	334,390
Mar 31, 2024	328,661
Dec 31, 2023	474,206
Sep 30, 2023	474,138
Jun 30, 2023	473,296
Mar 31, 2023	476,209
Dec 31, 2022	393,417
Sep 30, 2022	390,741
Jun 30, 2022	357,293
Mar 31, 2022	499,812
Dec 31, 2021	350,164
Sep 30, 2021	392,065
Jun 30, 2021	357,594
Mar 31, 2021	368,232
Dec 31, 2020	331,322
Sep 30, 2020	283,713
Jun 30, 2020	367,358
Mar 31, 2020	338,497
Dec 31, 2019	0
Sep 30, 2019	242,956
Jun 30, 2019	257,633
Mar 31, 2019	233,776
Dec 31, 2018	232,992
Sep 30, 2018	93,244
Jun 30, 2018	88,570
Mar 31, 2018	114,526
Dec 31, 2017	63,189
Sep 30, 2017	43,926
Jun 30, 2017	198,090
Mar 31, 2017	0
Dec 31, 2016	0
Sep 30, 2016	0
Jun 30, 2016	0
Mar 31, 2016	0